Eprobemide

Eprobemide

Eprobemide
Systematic (IUPAC) name
4-Chloro-N-[3-(4-morpholinyl)propyl]benzamide
Clinical data
Trade names Befol (RU)
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Registry Number
PubChem CID:
ChemSpider
Synonyms Befol
Chemical data
Formula C14H19ClN2O2
Molecular mass 282.77 g/mol

Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol).[1] It is a non-competitive reversible inhibitor of monoamine oxidase A[2][3] that exhibits selective action on serotonin deamination.[4] Eprobemide differs from moclobemide only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.[5]

References

  1. ^
  2. ^
  3. ^
  4. ^ Eprobemide, ChemIDplus
  5. ^